Expro Group Holdings N.V. is a leading international oilfield services company that specializes in well flow management and related technologies
The company provides a comprehensive suite of services including well testing, well intervention, and production optimization, aimed at maximizing the efficiency and safety of oil and gas production operations. By leveraging advanced technology and expertise, Expro helps its clients to enhance productivity, manage costs, and ensure environmental compliance throughout the lifecycle of oil and gas wells. With a global presence, Expro serves a diverse range of upstream energy companies across various regions, contributing to the optimization of hydrocarbon recovery and sustainable operations in the energy sector.
Companies Reporting Before The Bell • Gatos Silver (NYSEGATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Expro Gr Hldgs (NYSEXPRO) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
According to Benzinga Pro data, during Q2, Expro Group Holdings (NYSEXPRO) posted sales of $313.62 million. Earnings were up 60.92%, but Expro Group Holdings still reported an overall loss of $4.35 million.
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQMIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Companies Reporting Before The Bell
• SIGNA Sports United (NYSESSU) is expected to report quarterly loss at $0.04 per share on revenue of $283.61 million.
•...
Gainers
Spruce Biosciences, Inc. (NASDAQSPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Gainers
Genfit SA (NASDAQGNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.
X4 Pharmaceuticals, Inc...
Gainers
Arena Pharmaceuticals, Inc. (NASDAQARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...
